Tennis Star Maria Sharapova says she Failed Drug Test at Australian Open

Maria Sharapova (Photo: Robyn Beck, AFP/Getty Images)
Maria Sharapova (Photo: Robyn Beck, AFP/Getty Images)

Tennis star Maria Sharapova admitted Monday she failed a drug test.

“I take full responsibility for it,” she said. “I made a huge mistake. I let my fans down. I let my sport down.

“I don’t want to end my career this way. … I know many of you thought I was retiring. But if I was ever going to announce my retirement it would not be in this downtown Los Angeles hotel with this fairly ugly carpet.”

She said the drug’s name is Meldonium and had been prescribed by a doctor. She said she has a magnesium deficiency and a family history of diabetes. She said the drug was not on the banned list for the last 10 years but as of Jan. 1 the rules changed. She said she does not know yet how long she will be held out of competition. The test was done at the Australian Open in January.

Meldonium is used therapeutically as an anti-ischemic drug to treat patients with angina and myocardial infarction.

A statement from the World Anti-Doping Agency confirmed the drug was added to the banned list this year “because of evidence of its use by athletes with the intention of enhancing performance.”

After the press conference, her attorney, John Haggerty, said “a positive drug test could result in a ban of up to four years” from the International Tennis Federation. But he added that “mitigating circumstances can lead to the elimination of a ban altogether. … We’re still determining what we are going to request of them. I’ve asked them to have a cooperative process.”

The ITF posted a statement on its website from the Tennis Anti-Doping Program that included background on the failed test:

“On 26 January 2016, Ms Sharapova provided an anti-doping sample to the TADP in association with her participation in the 2016 Australian Open.

“That sample was analysed by a World Anti-Doping Agency (WADA) accredited laboratory, which returned a positive for meldonium, which is a prohibited substance under the WADA Code and, therefore also the TADP.

“In accordance with Article 8.1.1 of the TADP, Ms Sharapova was charged on 2 March with an Anti-Doping Rule Violation.

“Ms Sharapova has accepted the finding of meldonium in her sample collected on 26 January.

Click here to continue reading…

SOURCE: Josh Peter
USA TODAY Sports